Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Acta Gastro-Enterologica Belgica|August 1, 2002
Risk factors for hepatitis C: past, present and futureJ Delwaide, N Bourgeois, I Colle, et al.
Journal of Viral Hepatitis|November 25, 2003
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trialH Van Vlierberghe, G Leroux-Roels, M Adler, et al.
Journal of Medical Virology|July 16, 2013
Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infectionE Ho, P Deltenre, M Nkuize, et al.
Transplantation Proceedings|March 31, 2009
Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infectionG Robaeys, F Nevens, P Stärkel, et al.
Acta Gastro-Enterologica Belgica|March 20, 2019
A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016S Bourgeois, J P Mulkay, L Lasser, et al.
Alimentary Pharmacology & Therapeutics|July 1, 2004
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral responseJ Delwaide, N Bourgeois, C Gérard, et al.
Acta Gastro-Enterologica Belgica|April 19, 2005
Treatment of hepatitis C viral infections in substance abusersG Robaeys, F Buntinx
Revue Medicale De Liege|November 12, 1998
[Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)]J Delwaide
Alimentary Pharmacology & Therapeutics|March 3, 2018
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomesS Van Hees, S Bourgeois, H Van Vlierberghe, et al.
Acta Gastro-Enterologica Belgica|January 26, 2006
The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC?H Van Vlierberghe, I Colle, J Henrion, et al.
Pageof 33